Craneware, a specialist in medical billing software solutions, had a successful flotation on the Alternative Investment Market (AIM) in 2007, achieving a successful exit for SEP and the company’s other venture capital investors. (LSE:CRW) With a market cap of £42.7million at 7th April 2008, the company raised £4 million of new money in a share placing that was heavily over-subscribed.
Today, Craneware’s software is used by hospitals across the United States. The company’s development activity is based in Scotland with sales operations based in Florida and sales offices across the US.